Viestar (Suzhou) key facts
as of Oct 2026- Manufacturer of optoelectronic medical equipment and devices intended to provide medical professionals with advanced diagnosis and treatment tools.
- Viestar (Suzhou) is valued at approximately $19.1M as of Oct 2026 (last reported valuation).
- It has raised $22.7M; the latest was Later Stage VC ($14.0M) in Nov 2025.
- Notable investors include SND Ventures Group, Northern Light Venture Capital, Shenzhen Yifeng Investment Management Enterprise, Insight Capital (Taicang), Wuhan Changfei Industrial Fund Management — 8 tracked in total.
- Status: Privately Held (backing).
Viestar (Suzhou)'s last reported valuation, Jan 2017. Nothing priced has surfaced since.
- ·Watch Viestar (Suzhou): the Monday email on marks, rounds and moves
Viestar (Suzhou) funding rounds
No funding rounds for Viestar (Suzhou) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Viestar (Suzhou) valuation
Viestar (Suzhou)'s last reported valuation was $19.1 million in Jan 2017. No priced round, secondary trade or fund mark has surfaced since.
Viestar (Suzhou) investors
8 investors are on record for Viestar (Suzhou), including SND Ventures Group, Northern Light Venture Capital, Shenzhen Yifeng Investment Management Enterprise and Insight Capital (Taicang).
About Viestar (Suzhou)
Manufacturer of optoelectronic medical equipment and devices intended to provide medical professionals with advanced diagnosis and treatment tools. The company offers development and market expansion of the probe-type laser confocal microendoscope, thereby enabling medical professionals to improve early disease diagnosis technology and medical effects.
- Sector
- Healthcare
- HQ
- Ezhou, China
- Founded
- 2014
- Employees
- 21
- Website
- biopsee.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.